Pricing Log in Create free account

Capricor Therapeutics, Inc. (CAPR) vs Rezolute, Inc. (RZLT)

Capricor Therapeutics, Inc. and Rezolute, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and Rezolute, Inc. are of similar size ($471.1M and $455.2M). Across the 10 metrics below, Rezolute, Inc. leads on 6 and Capricor Therapeutics, Inc. on 4.

Valuation

Metric CAPR RZLT Biotechnology median
P/E n/m n/m 8.56
P/S 19.43 n/m 10.17
P/B 1.76 5.04 2.34
Price to free cash flow 3.31 n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 9.38 n/m 9.64
Earnings yield (32.80%) (15.57%) (29.41%)
Free cash flow yield 30.25% (12.90%) (23.50%)

Profitability

Metric CAPR RZLT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.70%) (59.04%) (56.66%)
Return on assets (51.53%) (53.82%) (49.22%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR RZLT Biotechnology median
Revenue growth (TTM) (11.55%) — 5.64%
EPS growth (last fiscal year) (96.52%) 23.47% 30.08%
Revenue growth, 5-year CAGR 85.83% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.35 9.68 4.72
Net debt to EBITDA 2.99 1.26 0.96

Dividend

Metric CAPR RZLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CAPR RZLT Biotechnology median
Market cap 455.23m 471.07m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack